All results

28 results for weight and metabolic health study

• Fasting ENHANCE

  Grounded in the principles of geroscience, the proposed Fasting ENHANCE study will test whether a time restricted eating (TRE) regimen can improve cognitive…

  Ages

  65 Years - N/A

  Sexes

  All

• Metabolic costs of daily activity in older adults: CHORES XL

  The work will evaluate the metabolic costs for daily activities across the lifespan and evaluate the influence of having functional impairments. The work will…

  Ages

  20 Years - N/A

  Sexes

  All

• Protocol TN-25

  The study is a two-arm, multicenter, double-blinded clinical trial testing sequential therapy with rituximab-pvvr followed by abatacept versus rituximab-pvvr…

  Ages

  8 Years - 45 Years

  Sexes

  All

• JNT-517

  The goal of Parts A and B of this Phase 1, first-in-human, randomized study is to assess the safety, tolerability, and pharmacokinetics (PK) of single (SAD)…

  Ages

  18 Years - 65 Years

  Sexes

  All

• PK sensitivity in fluticasone propionate dry powder inhalers

  When a drug company first develops a drug, the company has to show the Food and Drug Administration (FDA) that the drug is safe and effective. If FDA concludes…

  Ages

  18 Years - 50 Years

  Sexes

  All

• Vertex 668

  The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of VX-668 at various doses. This clinical trial information was…

  Ages

  18 Years - 55 Years

  Sexes

  All

• TN-31 JAKPOT T1D

  A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and…

  Ages

  12 Years - 35 Years

  Sexes

  All

• VX-634

  The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of VX-634 at various doses. This clinical trial information was…

  Ages

  18 Years - 55 Years

  Sexes

  All

• OxyAging

  Some research suggests that administration of oxytocin with oxycodone may reduce its abuse liability and improve its ability to reduce pain. In a 6-session…

  Ages

  45 Years - 85 Years

  Sexes

  All

• CardiAMP

  This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham…

  Ages

  21 Years - 90 Years

  Sexes

  All